TARSUS Trademark

Trademark Overview

On Tuesday, February 16, 2021, a trademark application was filed for TARSUS with the United States Patent and Trademark Office. The USPTO has given the TARSUS trademark a serial number of 90531221. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Tarsus Pharmaceuticals, Inc.. The TARSUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, therapies, diseases, and disorders
tarsus

General Information

Serial Number90531221
Word MarkTARSUS
Filing DateTuesday, February 16, 2021
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7402367
Registration DateTuesday, May 28, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements

Description of MarkThe mark consists of the stylized wording TARSUS underneath a graphic of a circle with a T inside.
NOT AVAILABLE"TARSUS"
Goods and ServicesPharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, therapies, diseases, and disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code042
First Use Anywhere DateSunday, February 21, 2021
First Use In Commerce DateSunday, February 21, 2021

Trademark Owner History

Party NameTarsus Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameTarsus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameTarsus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Friday, February 19, 2021NEW APPLICATION ENTERED
Wednesday, May 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 20, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 29, 2021ASSIGNED TO EXAMINER
Monday, July 12, 2021NON-FINAL ACTION WRITTEN
Monday, July 12, 2021NON-FINAL ACTION E-MAILED
Monday, July 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 15, 2022NON-FINAL ACTION WRITTEN
Tuesday, February 15, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 19, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 19, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 31, 2023FINAL REFUSAL WRITTEN
Wednesday, May 31, 2023FINAL REFUSAL E-MAILED
Wednesday, May 31, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 7, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 4, 2024USE AMENDMENT FILED
Friday, March 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, March 4, 2024TEAS STATEMENT OF USE RECEIVED
Friday, March 22, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 22, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 22, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, April 24, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

tarsus research pharmaceuticals therapies disorders fields diseases scientific development providing medical